RA Capital Nexus Fund III, L.P. - Insider Non-Derivative Transactions at Mineralys Therapeutics, Inc. (MLYS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 14, 2023, RA Capital Nexus Fund III, L.P.'s relationship to Mineralys Therapeutics, Inc. (MLYS) is Director, and currently has 1,867,229 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other MLYS insiders.
Data Source: SEC.
RA Capital Nexus Fund III, L.P. - Insider Non-Derivative Transactions at MLYS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 15, 2023 | C -- (Common Stock) | 192847 | 0 | 192847 |
| Feb 15, 2023 | P -- (Common Stock) | 1118400 | 16 | 1311247 |
| Feb 15, 2023 | C -- (Common Stock) | 1735629 | 0 | 1735629 |
| Feb 15, 2023 | P -- (Common Stock) | 131600 | 16 | 1867229 |